Form 4: Paychex Director Joseph Velli Receives New Equity Awards
Insider Transaction Report
Paychex Inc. Director Joseph M. Velli was granted 164 restricted stock units and 670 stock options as part of the company's 2002 Stock Incentive Plan.
Summary
- Joseph M. Velli, a Director at Paychex Inc. (PAYX), received new equity awards on July 15, 2025.
- The awards include 164 shares of common stock in the form of restricted stock units (RSUs), subject to vesting.
- Additionally, 670 stock options were granted with an exercise price of $140.68, becoming exercisable on July 15, 2026, and expiring on July 14, 2035.
- Following these transactions, Mr. Velli directly beneficially owns 78,619 shares of common stock.
- His total derivative holdings now include 52,603 stock options across various grants with exercise prices ranging from $57.20 to $140.68 and expiration dates up to July 14, 2035.
Sentiment
Score: 7
Explanation: The grant of equity awards to a director is generally a positive sign of alignment between management and shareholder interests, and a routine part of compensation. It does not indicate any negative operational or financial issues for the company.
Positives
- The grant of 164 restricted stock units (RSUs) and 670 stock options aligns the director's interests with long-term shareholder value.
- The awards are part of the company's Amended and Restated 2002 Stock Incentive Plan, indicating a structured approach to executive compensation.
Negatives
- The issuance of new equity awards, even if small, can lead to minor dilution for existing shareholders.
Risks
- No specific new risks are identified in this Form 4 filing beyond the general implications of stock-based compensation.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Plan Utilization | The equity awards were granted pursuant to the Amended and Restated 2002 Stock Incentive Plan, demonstrating the ongoing use of the company's established equity compensation framework. | 07/15/2025 | Reinforces alignment of director incentives with long-term company performance and shareholder value. |
Related Party Transactions
- The transaction represents an equity award to a director, which is a form of related party transaction, specifically compensation.
Stakeholder Impact
- Shareholders: Minor potential dilution from the issuance of new shares/options, but also improved alignment of director's interests with shareholder value.
- Director (Joseph M. Velli): Receives additional equity compensation, increasing his stake and potential future wealth tied to company performance.
Next Steps
- The restricted stock units are subject to vesting, implying future milestones or time-based conditions for full ownership.
Key Dates
| Date | Description |
|---|---|
| 07/07/2017 | Date stock options with an exercise price of $60.59 became exercisable. |
| 07/13/2018 | Date stock options with an exercise price of $57.20 became exercisable. |
| 07/12/2019 | Date stock options with an exercise price of $70.37 became exercisable. |
| 07/11/2020 | Date stock options with an exercise price of $85.33 became exercisable. |
| 07/15/2021 | Date stock options with an exercise price of $73.53 became exercisable. |
| 07/15/2022 | Date stock options with an exercise price of $112.67 became exercisable. |
| 07/15/2023 | Date stock options with an exercise price of $115.00 became exercisable. |
| 07/15/2024 | Date stock options with an exercise price of $120.86 became exercisable. |
| 07/15/2025 | Date of transaction for new restricted stock units and stock options. |
| 07/17/2025 | Signature date of the reporting person's attorney-in-fact. |
| 07/14/2026 | Expiration date for stock options with an exercise price of $60.59. |
| 07/15/2026 | Date new stock options with an exercise price of $140.68 become exercisable. |
| 07/12/2027 | Expiration date for stock options with an exercise price of $57.20. |
| 07/11/2028 | Expiration date for stock options with an exercise price of $70.37. |
| 07/10/2029 | Expiration date for stock options with an exercise price of $85.33. |
| 07/14/2030 | Expiration date for stock options with an exercise price of $73.53. |
| 07/14/2031 | Expiration date for stock options with an exercise price of $112.67. |
| 07/14/2032 | Expiration date for stock options with an exercise price of $115.00. |
| 07/14/2033 | Expiration date for stock options with an exercise price of $120.86. |
| 07/14/2034 | Expiration date for stock options with an exercise price of $121.63. |
| 07/14/2035 | Expiration date for new stock options with an exercise price of $140.68. |
Keywords
Paychex, PAYX, Joseph M. Velli, Director, SEC Form 4, insider transaction, restricted stock units, RSUs, stock options, equity award, beneficial ownership, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.